Skip to content
Valneva SE icon

Valneva SE

VLA.PAStocksBiotechnologyFranceEuronext ParisEUR

Price

€2.60

Today

-2.7%

YTD

-28.0%

About

Valneva SE is a French specialty vaccine company dedicated to developing and commercialising innovative prophylactic vaccines. Its primary aim is to protect people from infectious diseases through new preventative solutions, operating internationally. Operating within the biotechnology and healthcare sector, Valneva SE focuses on developing vaccines for diseases with significant unmet medical needs. Its approach aims to provide effective preventative measures that contribute to global public health. Keep up to date on the latest share price changes by adding VLA.PA stock to your eToro virtual portfolio. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for VLA.PA (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.71
P/S (TTM)2.40
P/B (TTM)4.89
Market cap$413.24M
Cap tierSmall-cap
Industry avg P/E-6.24

Profitability

Gross margin29.46%
EBIT margin-70.34%
Net margin-103.78%
ROE-109.57%
ROA-32.32%

Earnings & Revenue

Revenue (TTM)$156.33M
Revenue growth (1Y)-16.0%
EPS (TTM)-$0.80
Free cash flow$-76.94M
Total debt$209.50M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.16
Employees674
Next earnings17 Mar '27
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Valneva SE (VLA.PA) | Dirk Kuyken